Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |